Maxygen, Inc. (NASDAQ:MAXY)

CAPS Rating: 4 out of 5

A biotechnology company committed to the discovery and development of improved next-generation protein pharmaceuticals for the treatment of disease and serious medical conditions.

Recs

0
Player Avatar lanning01 (< 20) Submitted: 2/25/2007 5:49:38 PM : Outperform Start Price: $9.91 MAXY Score: -37.10

Momentum play with pull back on a bad dow day

Featured Broker Partners


Advertisement